Teriparatide

3 trials 1 recruiting HEndocrinology

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

1 Recruiting

1 Completed trials

4 Sponsors

5 Countries

Phase IV

Phase IV: 3

Sponsors using this IMP

Gedeon Richter Iberica S.A. 1 Herlev Hospital 1 NHS Lothian 1 University Of Edinburgh 1

All trials

3 total

Prospective, randomized, multicentre study to compare the efficacy at 52 weeks (1 year) of biosimilar teriparatide and alendronate in the pr… Pending

2025-521301-40-00 Phase IV 1 country Gedeon Richter Iberica S.A.
Treatment of adynamic bone disorder with parathyroid hormone in patients with chronic kidney disease Recruiting

2023-506853-39-00 Phase IV 1 country Herlev Hospital
Treatment of Osteogenesis Imperfecta with Parathyroid hormone and Zoledronic acid Ended

2024-519705-36-00 Phase IV 4 countries NHS Lothian; University Of Edinburgh

Showing 1–3 of 3 trials

← All drugs A–Z